Erasca, Inc. (ERAS)
14.41
+1.14
(+8.59%)
USD |
NASDAQ |
Nov 06, 16:00
14.52
+0.11
(+0.76%)
After-Hours: 20:00
Erasca Total Long Term Debt (Quarterly) : 39.27M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 39.27M |
| March 31, 2026 | 40.70M |
| December 31, 2025 | 42.07M |
| September 30, 2025 | 43.41M |
| June 30, 2025 | 44.71M |
| March 31, 2025 | 46.02M |
| December 31, 2024 | 47.27M |
| September 30, 2024 | 48.49M |
| June 30, 2024 | 49.68M |
| March 31, 2024 | 57.72M |
| December 31, 2023 | 51.89M |
| September 30, 2023 | 52.94M |
| June 30, 2023 | 53.97M |
| Date | Value |
|---|---|
| March 31, 2023 | 54.94M |
| December 31, 2022 | 53.79M |
| September 30, 2022 | 53.43M |
| June 30, 2022 | 27.44M |
| March 31, 2022 | 29.42M |
| December 31, 2021 | 18.51M |
| September 30, 2021 | 19.37M |
| June 30, 2021 | 1.668M |
| March 31, 2021 | 1.875M |
| December 31, 2020 | 2.109M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Twist Bioscience Corp. | 84.96M |
| Immunome, Inc. | 4.588M |
| Oncolytics Biotech, Inc. | 0.31M |
| Sangamo Therapeutics, Inc. | 19.33M |